glp 1 agonists and sglt2 inhibitors Common systemic effects of either or GLP-1R Use of GLP-1 Receptor Agonists
Description
None of these effects require a functioning beta cell which is exactly why researchers started exploring them in T1D
2026 Jan 08
The partnership with HealthifyMe at Fortis Hospital, Mohali bridges digital coaching with clinical care
Effects of liraglutide on cardiovascular outcomes in type 2 diabetes patients with and without baseline metformin use: post hoc analyses of the LEADER trial
Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
Effects of glucagon-like peptide-1 receptor agonists on upper endoscopy in diabetic and non-diabetic patients
